Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Healthy

Interventions

DRUG

Clobetasol Propionate 0.05% lotion, single exposure

A: Experimental Subjects received Alpharma USPD, Inc formulated products

DRUG

Clobex TM 0.05% Lotion, single exposure

B:Active Comparator Subjects received Galderma Laboratories, L.P. formulated products

Trial Locations (1)

Novum Pharmaceutical Research Services, Houston